References

1. Allon M, Campbell XG Jr, Nasr SA et al. Minimal change glomerulonephropathy and interstial infiltration with mycosis fungoides. The american journal of Medicine. 1988; 84:756-59. This article on PubMed


2. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sesary syndrome: validation of the revised international society for cutaneous lymphomas/European organization for research and treatment of cancer staging proposal. J Clin Oncol. 2010; 28:4730-47. This article on PubMed


3. Dauchy FA, Etienne G, Deminière C, Combe C, Merville P, Longy-Boursier M. Lymphoma with initial renal involvement: four cases. Rev Med Interne. 2006 Dec;27(12):909-15. This article on PubMed


4. Willemze R,Jaffe, ES. Who-EORTC Classification for cutaneous lymphomas. Blood. 2005; 105:3768-85. This article on PubMed


5. Epstein EHJ, Levin DL. Mycosis fungoides - Survival, prognostic features, response to therapy, and autopsy findings. Medicine (Baltimore). 1972; 51: 61-72. This article on PubMed


6. Abel EA, Wood GS, Hoppe RT. Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to treatment. CA Cancer J Clin. 1993; 43: 93-115. This article on PubMed


7. Donckerwolcke R,Cameron J.The nephrotic syndrome.In: Davidson A,Cameron J, Grunfeld J, Ponticelli C, Ritz E,Winearls C, et al.Oxford textbook of clinical nephrology.Oxford:Oxford university Press 2005: 415-38


8. Hala Alsehayeb, Barry M Wall. Non hodgkin’s lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy. Cases Journal. 2009; 2: 7201. This article on PubMed


9. Shaloub RJ. Pathogenesis of lipoid nephrosis: a disorder of T cell function. Lancet. 1974 Sep 7;2(7880):556-60. This article on PubMed


10. Lagrue G, Xheneumont S, Branellec A, Weil B. Letter: Lymphokines and nephrotic syndrome. Lancet. 1975 Feb 1;1(7901):271-2. This article on PubMed